Compound ID | 1390
Class: Quinazolinone (PBP1 and 2a inhibitor)
| Spectrum of activity: | Gram-positive |
| Details of activity: | MRSA |
| Institute where first reported: | Area of Biochemistry and Molecular Biology, University of La Rioja, Logroño, Spain |
| Year first mentioned: | 2019 |
| Highest developmental phase: | Preclinical |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| Citation: | https://aac.asm.org/content/64/1/e01344-19 |